Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-28

FDA Approved: SAMSCA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SAMSCA (tolvaptan) filed by Otsuka America Pharmaceutical, Inc. The action updates the product labeling under the su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Samsca (tolvaptan)

Snippet

SUPPL AP for SAMSCA (TOLVAPTAN)